Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd
Hirohisa Nakamae, Hirohiko Shibayama, Mineo Kurokawa, Tetsuya Fukuda, Chiaki Nakaseko, Yoshinobu Kanda, Tadashi Nagai, Kazunori Ohnishi, Yasuhiro Maeda, Akira Matsuda, Taro Amagasaki, Masamitsu YanadaVolume:
93
Language:
english
Pages:
9
DOI:
10.1007/s12185-011-0841-8
Date:
May, 2011
File:
PDF, 289 KB
english, 2011